Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 9/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | MAOA | P21397 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4185977 | 0.78 | KDM4E (0.68) | KCNA3KDM4EALDH1A1TSHRMAPK1 | |
| SCHEMBL8416177 | 0.75 | CYP3A4 (0.64) | KCNA3KDM4EALDH1A1TSHRMAPK1 | |
| SCHEMBL10405129 | 0.73 | ALDH1A1 (0.60) | KDM4EALDH1A1TSHRMAPK1CYP3A4 | |
| SCHEMBL9120159 | 0.72 | ALDH1A1 (0.63) | KCNA3KDM4EALDH1A1TSHRCYP3A4 | |
| SCHEMBL31516460 | 0.72 | ALDH1A1 (0.63) | KCNA3KDM4EALDH1A1TSHRCYP3A4 | |
| SCHEMBL27987501 | 0.71 | GAA (0.56) | KDM4EALDH1A1MAPK1CYP3A4MAOA | |
| SCHEMBL8750107 | 0.71 | ALDH1A1 (0.48) | KDM4EALDH1A1MAPK1CYP3A4MAOA | |
| SCHEMBL6545566 | 0.71 | KDM4E (0.62) | KCNA3KDM4EALDH1A1TSHRMAPK1 | |
| SCHEMBL18073906 | 0.71 | KCNA3 (0.76) | KCNA3KDM4EALDH1A1TSHRCA9 | |
| SCHEMBL18073923 | 0.71 | KCNA3 (1.00) | KCNA3KDM4EALDH1A1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0579784-B1 | METHOD FOR PREVENTING RESTENOSIS FOLLOWING RECONFIGURATION OF BODY VESSELS | ADVANCED RES & TECH INST (US) | 1999-11-10 | — | — | EP | claimed |
| US-5219882-A | Treatment methods for lymes disease and associated debilitating conditions | BISACCIA EMIL (US) | 1993-06-15 | — | — | US | claimed |
| EP-0453497-A4 | TREATMENT METHODS AND VACCINES | — | 1992-10-07 | — | — | EP | claimed |
| US-5116864-A | Method for preventing restenosis following reconfiguration of body vessels | INDIANA UNIVERSITY FOUNDATION (US) | 1992-05-26 | — | — | US | claimed |
| EP-0453497-A1 | TREATMENT METHODS AND VACCINES | BISACCIA, Emil (US) | 1991-10-30 | — | — | EP | claimed |
| US-4960408-A | ADMINISTERING A PSORALEN COMPOUND, EXPOSING TO ELECTROMAGNETIC RADIATION | KLAINER ALBERT S (US) | 1990-10-02 | — | — | US | claimed |
| WO-1990007952-A1 | TREATMENT METHODS AND VACCINES | BISACCIA EMIL (US) | 1990-07-26 | — | — | WO | claimed |
| US-4748120-A | Photochemical decontamination treatment of whole blood or blood components | DIAMOND SCIENTIFIC CO. (US) | 1988-05-31 | — | — | US | claimed |
| WO-2023164075-A1 | THERMOSTABLE UV INACTIVATED VACCINES AND OTHER BIOPHARMACEUTICALS | UNIVERSAL STABILIZATION TECHNOLOGIES INC. (US) | 2023-08-31 | — | — | WO | disclosed |
| US-20220168411-A1 | PSORALEN-INACTIVATED CORONAVIRUS VACCINE AND METHOD OF PREPARATION | THE UNITED STATES OF AMERICAN AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2022-06-02 | — | — | US | disclosed |
| US-20150291936-A1 | PSORALEN-INACTIVATED DENGUE VIRUS VACCINE AND METHOD OF PREPARATION | THE UNITED STATES OF AMERICAN AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2015-10-15 | — | — | US | disclosed |
| US-9005633-B2 | Psoralen-inactivated viral vaccine and method of preparation | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY. (US) | 2015-04-14 | — | — | US | disclosed |
| US-20110014233-A1 | PSORALEN-INACTIVATED VIRAL VACCINE AND METHOD OF PREPARATION | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2011-01-20 | — | — | US | disclosed |
| WO-2004101805-A1 | METHOD FOR RECOMBINANT PRODUCTION OF MAMMALIAN PROTEINS AND PROTEINS OBTAINABLE BY SUCH METHOD | AXXIMA PHARMACEUTICALS AG (DE) | 2004-11-25 | — | — | WO | disclosed |
| US-4545987-A | Psoralen inactivated double-stranded RNA viral vaccines | ADVANCED GENETICS RESEARCH INSTITUTE (US) | 1985-10-08 | — | — | US | disclosed |
| EP-0030358-B1 | APPARATUS FOR REDUCING THE FUNCTIONING LYMPHOCYTE POPULATION IN BLOOD | LEUKOCYTE RESEARCH, INC. (US) | 1985-03-27 | — | — | EP | disclosed |
| EP-0124363-A2 | Photochemical decontamination treatment of whole blood or blood components | DIAMOND SCIENTIFIC CO. (US) | 1984-11-07 | — | — | EP | disclosed |
| US-4321919-A | Method and system for externally treating human blood | LEUKOCYTE RESEARCH, INC. (US) | 1982-03-30 | — | — | US | disclosed |
| US-4279922-A | Photosensitizing benzofuranacrylics | THOMAS C. ELDER, INC. (US) | 1981-07-21 | — | — | US | disclosed |
| EP-0030358-A2 | Apparatus for reducing the functioning lymphocyte population in blood | LEUKOCYTE RESEARCH, INC. (US) | 1981-06-17 | — | — | EP | disclosed |